Concepedia

Is anti-factor Xa chromogenic assay for Rivaroxaban appropriate in clinical practice? Advantages and comparative drawbacks

Guillaume Bardy, Florence Fischer, Anny Appert, Bernadette Baldin, Marie Stève, A Spreux, Thibaud Lavrut, Milou‐Daniel Drici

Thrombosis Research · 2015 · 20 citations · 23 references

DOI

Concepts

References

23

STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT

J Martin Bland, DouglasG. Altman · The Lancet · 1986 · 47.6K citations

, , +7

Akufo and Ibarapa

A H BECKETT, M ROWLAND, P TURNER · The Lancet · 1965 · 16.9K citations

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

Stuart J. Connolly, Michael D. Ezekowitz, Salim Yusuf et al. · New England Journal of Medicine · 2009 · 11.2K citations · Full text

, , +12

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

Manesh R. Patel, Kenneth W. Mahaffey, Jyotsna Garg et al. · New England Journal of Medicine · 2011 · 9.4K citations · Full text

, , +15

Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)

A. John Camm, Paulus Kirchhof, Gregory Y.H. Lip et al. · European Heart Journal · 2010 · 5.9K citations · Full text

, , +12